O	0	8	Dominant	Dominant	JJ	B-NP
O	9	17	negative	negative	JJ	I-NP
O	18	30	interference	interference	NN	I-NP
O	31	33	of	of	IN	B-PP
O	34	47	transcription	transcription	NN	B-NP
O	48	54	factor	factor	NN	I-NP
O	55	57	AP	AP	NN	I-NP
O	57	58	-	-	HYPH	O
O	58	59	2	2	CD	B-NP
O	60	66	causes	cause	VBZ	B-VP
O	67	77	inhibition	inhibition	NN	B-NP
O	78	80	of	of	IN	B-PP
O	81	85	ErbB	ErbB	NN	B-NP
O	85	86	-	-	HYPH	O
O	86	87	3	3	CD	B-NP
O	88	98	expression	expression	NN	I-NP
O	99	102	and	and	CC	O
O	103	113	suppresses	suppress	VBZ	B-VP
B-Cell	114	123	malignant	malignant	JJ	B-NP
I-Cell	124	128	cell	cell	NN	I-NP
O	129	135	growth	growth	NN	I-NP
O	135	136	.	.	.	O

O	138	142	ErbB	ErbB	NN	B-NP
O	142	143	-	-	HYPH	B-NP
O	143	144	3	3	CD	I-NP
O	145	146	(	(	(	O
O	146	150	HER3	HER3	NN	B-NP
O	150	151	)	)	)	O
O	152	154	is	be	VBZ	B-VP
O	155	156	a	a	DT	B-NP
O	157	163	member	member	NN	I-NP
O	164	166	of	of	IN	B-PP
O	167	170	the	the	DT	B-NP
O	171	180	epidermal	epidermal	JJ	I-NP
O	181	187	growth	growth	NN	I-NP
O	188	194	factor	factor	NN	I-NP
O	195	203	receptor	receptor	NN	I-NP
O	204	210	family	family	NN	I-NP
O	210	211	.	.	.	O

O	212	222	Increasing	Increase	VBG	B-NP
O	223	231	evidence	evidence	NN	I-NP
O	232	240	suggests	suggest	VBZ	B-VP
O	241	245	that	that	IN	B-SBAR
O	246	254	elevated	elevate	VBN	B-NP
O	255	265	expression	expression	NN	I-NP
O	266	268	of	of	IN	B-PP
O	269	273	ErbB	ErbB	NN	B-NP
O	273	274	-	-	HYPH	B-NP
O	274	275	3	3	CD	I-NP
O	276	278	is	be	VBZ	B-VP
O	279	288	important	important	JJ	B-ADJP
O	289	292	for	for	IN	B-PP
O	293	303	malignancy	malignancy	NN	B-NP
O	303	304	.	.	.	O

O	305	307	In	In	IN	B-PP
O	308	312	this	this	DT	B-NP
O	313	318	study	study	NN	I-NP
O	318	319	,	,	,	O
O	320	322	we	we	PRP	B-NP
O	323	328	found	find	VBD	B-VP
O	329	333	that	that	IN	B-SBAR
O	334	342	elevated	elevate	VBN	B-NP
O	343	349	levels	level	NNS	I-NP
O	350	352	of	of	IN	B-PP
O	353	357	ErbB	ErbB	NN	B-NP
O	357	358	-	-	HYPH	O
O	358	359	3	3	CD	B-NP
O	360	370	expression	expression	NN	I-NP
O	371	374	did	do	VBD	B-VP
O	375	378	not	not	RB	I-VP
O	379	384	occur	occur	VB	I-VP
O	385	387	in	in	IN	B-PP
O	388	391	the	the	DT	B-NP
O	392	399	absence	absence	NN	I-NP
O	400	402	of	of	IN	B-PP
O	403	405	AP	AP	NN	B-NP
O	405	406	-	-	HYPH	B-NP
O	406	412	2gamma	2gamma	NN	I-NP
O	413	415	in	in	IN	B-PP
O	416	417	a	a	DT	B-NP
O	418	423	panel	panel	NN	I-NP
O	424	426	of	of	IN	B-PP
O	427	432	human	human	JJ	B-NP
B-Cell	433	440	mammary	mammary	JJ	I-NP
I-Cell	441	451	epithelial	epithelial	JJ	I-NP
O	452	455	and	and	CC	I-NP
B-Cell	456	467	fibroblasts	fibroblast	NNS	I-NP
I-Cell	468	472	cell	cell	NN	I-NP
I-Cell	473	478	lines	line	NNS	I-NP
O	478	479	.	.	.	O

O	480	482	In	In	IN	B-PP
O	483	491	contrast	contrast	NN	B-NP
O	491	492	,	,	,	O
O	493	498	there	there	EX	B-NP
O	499	502	was	be	VBD	B-VP
O	503	505	no	no	DT	B-NP
O	506	517	association	association	NN	I-NP
O	518	525	between	between	IN	B-PP
O	526	529	the	the	DT	B-NP
O	530	540	expression	expression	NN	I-NP
O	541	543	of	of	IN	B-PP
O	544	546	AP	AP	NN	B-NP
O	546	547	-	-	HYPH	B-NP
O	547	553	2alpha	2alpha	NN	I-NP
O	554	556	or	or	CC	I-NP
O	557	559	AP	AP	NN	I-NP
O	559	560	-	-	HYPH	B-NP
O	560	565	2beta	2beta	NN	I-NP
O	566	569	and	and	CC	O
O	570	573	the	the	DT	B-NP
O	574	579	level	level	NN	I-NP
O	580	582	of	of	IN	B-PP
O	583	587	ErbB	ErbB	NN	B-NP
O	587	588	-	-	HYPH	B-NP
O	588	589	3	3	CD	I-NP
O	589	590	,	,	,	O
O	591	593	or	or	CC	O
O	594	601	between	between	IN	B-PP
O	602	604	AP	AP	NN	B-NP
O	604	605	-	-	HYPH	I-NP
O	605	611	2alpha	2alpha	NN	I-NP
O	612	615	and	and	CC	I-NP
O	616	618	AP	AP	NN	I-NP
O	618	619	-	-	HYPH	B-NP
O	619	625	2gamma	2gamma	NN	I-NP
O	626	632	double	double	JJ	I-NP
O	633	643	positivity	positivity	NN	I-NP
O	644	647	and	and	CC	I-NP
O	648	652	ErbB	ErbB	NN	I-NP
O	652	653	-	-	HYPH	O
O	653	654	3	3	CD	B-NP
O	655	665	expression	expression	NN	I-NP
O	665	666	.	.	.	O

O	667	669	In	In	IN	B-PP
O	670	672	co	co	AFX	B-NP
O	672	673	-	-	HYPH	I-NP
O	673	685	transfection	transfection	NN	I-NP
O	686	697	experiments	experiment	NNS	I-NP
O	697	698	,	,	,	O
O	699	708	exogenous	exogenous	JJ	B-NP
O	709	719	expression	expression	NN	I-NP
O	720	722	of	of	IN	B-PP
O	723	725	AP	AP	NN	B-NP
O	725	726	-	-	HYPH	B-NP
O	726	732	2gamma	2gamma	NN	I-NP
O	733	741	robustly	robustly	RB	B-ADVP
O	742	751	activated	activate	VBD	B-VP
O	752	756	ErbB	ErbB	NN	B-NP
O	756	757	-	-	HYPH	B-NP
O	757	758	3	3	CD	I-NP
O	759	767	promoter	promoter	NN	I-NP
O	768	776	activity	activity	NN	I-NP
O	776	777	.	.	.	O

O	778	786	Moreover	Moreover	RB	B-ADVP
O	786	787	,	,	,	O
O	788	798	expression	expression	NN	B-NP
O	799	801	of	of	IN	B-PP
O	802	803	a	a	DT	B-NP
O	804	812	dominant	dominant	JJ	I-NP
O	813	821	negative	negative	JJ	I-NP
O	822	824	AP	AP	NN	I-NP
O	824	825	-	-	HYPH	B-NP
O	825	826	2	2	CD	I-NP
O	827	834	protein	protein	NN	I-NP
O	834	835	,	,	,	O
O	836	838	AP	AP	NN	B-NP
O	838	839	-	-	HYPH	B-NP
O	839	845	2delta	2delta	NN	I-NP
O	846	847	(	(	(	O
O	847	854	deleted	delete	VBN	B-NP
O	855	863	residues	residue	NNS	I-NP
O	864	866	31	31	CD	B-NP
O	866	867	-	-	HYPH	I-NP
O	867	870	117	117	CD	I-NP
O	870	871	)	)	)	O
O	871	872	,	,	,	O
O	873	876	not	not	RB	B-CONJP
O	877	881	only	only	RB	I-CONJP
O	882	891	repressed	repress	VBD	B-VP
O	892	895	the	the	DT	B-NP
O	896	900	ErbB	ErbB	NN	I-NP
O	900	901	-	-	HYPH	B-NP
O	901	902	3	3	CD	I-NP
O	903	911	promoter	promoter	NN	I-NP
O	912	920	activity	activity	NN	I-NP
O	921	924	but	but	CC	B-CONJP
O	925	929	also	also	RB	I-CONJP
O	930	940	suppressed	suppress	VBD	B-VP
O	941	951	endogenous	endogenous	JJ	B-NP
O	952	956	ErbB	ErbB	NN	I-NP
O	956	957	-	-	HYPH	B-NP
O	957	958	3	3	CD	I-NP
O	959	972	transcription	transcription	NN	I-NP
O	973	975	in	in	IN	B-PP
O	976	979	the	the	DT	B-NP
O	980	984	ErbB	ErbB	NN	I-NP
O	984	985	-	-	HYPH	B-NP
O	985	986	3	3	CD	I-NP
O	987	1001	overexpressing	overexpresse	VBG	I-NP
B-Cell	1002	1006	cell	cell	NN	I-NP
I-Cell	1007	1011	line	line	NN	I-NP
I-Cell	1012	1015	MRC	MRC	NN	I-NP
I-Cell	1015	1016	-	-	HYPH	B-NP
I-Cell	1016	1019	5VA	5VA	NN	I-NP
O	1019	1020	.	.	.	O

O	1021	1035	Overexpression	Overexpression	NN	B-NP
O	1036	1038	of	of	IN	B-PP
O	1039	1041	AP	AP	NN	B-NP
O	1041	1042	-	-	HYPH	B-NP
O	1042	1044	2A	2A	NN	I-NP
O	1045	1053	resulted	result	VBD	B-VP
O	1054	1056	in	in	IN	B-PP
O	1057	1058	a	a	DT	B-NP
O	1059	1068	decreased	decrease	VBN	I-NP
O	1069	1082	proliferation	proliferation	NN	I-NP
O	1083	1087	rate	rate	NN	I-NP
O	1088	1091	and	and	CC	O
O	1092	1101	inhibitin	inhibitin	NN	B-NP
O	1102	1104	of	of	IN	B-PP
B-Cell	1105	1111	colony	colony	NN	B-NP
O	1112	1121	formation	formation	NN	I-NP
O	1121	1122	.	.	.	O

O	1123	1128	Taken	Take	VBN	B-VP
O	1129	1137	together	together	RB	B-ADVP
O	1137	1138	,	,	,	O
O	1139	1144	these	these	DT	B-NP
O	1145	1149	data	datum	NNS	I-NP
O	1150	1158	strongly	strongly	RB	B-ADVP
O	1159	1166	support	support	VBP	B-VP
O	1167	1168	a	a	DT	B-NP
O	1169	1173	role	role	NN	I-NP
O	1174	1177	for	for	IN	B-PP
O	1178	1181	the	the	DT	B-NP
O	1182	1184	AP	AP	NN	I-NP
O	1184	1185	-	-	HYPH	I-NP
O	1185	1186	2	2	CD	I-NP
O	1187	1191	gene	gene	NN	I-NP
O	1192	1198	family	family	NN	I-NP
O	1198	1199	,	,	,	O
O	1200	1202	in	in	IN	B-PP
O	1203	1213	particular	particular	JJ	B-NP
O	1213	1214	,	,	,	I-NP
O	1215	1217	AP	AP	NN	I-NP
O	1217	1218	-	-	HYPH	I-NP
O	1218	1224	2gamma	2gamma	NN	B-NP
O	1224	1225	,	,	,	O
O	1226	1228	in	in	IN	B-PP
O	1229	1232	the	the	DT	B-NP
O	1233	1240	control	control	NN	I-NP
O	1241	1243	of	of	IN	B-PP
O	1244	1248	ErbB	ErbB	NN	B-NP
O	1248	1249	-	-	HYPH	O
O	1249	1250	3	3	CD	B-NP
O	1251	1261	expression	expression	NN	I-NP
O	1261	1262	.	.	.	O

O	1263	1275	Interference	Interference	NN	B-NP
O	1276	1280	with	with	IN	B-PP
O	1281	1284	the	the	DT	B-NP
O	1285	1293	function	function	NN	I-NP
O	1294	1296	of	of	IN	B-PP
O	1297	1310	transcription	transcription	NN	B-NP
O	1311	1317	factor	factor	NN	I-NP
O	1318	1320	AP	AP	NN	I-NP
O	1320	1321	-	-	HYPH	O
O	1321	1322	2	2	CD	B-NP
O	1323	1328	might	might	MD	B-VP
O	1329	1336	provide	provide	VB	I-VP
O	1337	1338	a	a	DT	B-NP
O	1339	1348	potential	potential	JJ	I-NP
O	1349	1357	strategy	strategy	NN	I-NP
O	1358	1361	for	for	IN	B-PP
O	1362	1372	modulation	modulation	NN	B-NP
O	1373	1375	of	of	IN	B-PP
O	1376	1379	the	the	DT	B-NP
O	1380	1389	malignant	malignant	JJ	I-NP
O	1390	1399	phenotype	phenotype	NN	I-NP
O	1399	1400	.	.	.	O

